In Conversation

“ Strengthening Europe’s competitiveness and improving patient access go hand in hand ”
“ Our aim is clear: continue to outgrow the German market ”
“ We are not driven by volume, but by creating value in rare diseases ”
“ The decisions we take today will determine which options patients have tomorrow ”
“ We need to build a successful and sustainable business while contributing to a future in which treatments are accessible ”
“ Innovators should hold CDMOs to a high bar, and CDMOs need to step up ”
“ Building stronger bridges between Korean biotech companies and global capital will be critical to unlocking the ecosystem’s full potential ”
“ Collaboration across institutions is not optional – it is necessary. The pace and complexity of the challenges demand it. ”
“ The biggest opportunity is to dare more, invest in promising ideas and become better at translating our excellent science into successful businesses ”
“ The opportunity to continue growing the organisation, while driving performance and innovation, remains a strong source of motivation ”
“ Our manufacturing base may be local, but the customers we serve and the products we manufacture are truly global ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here